The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma.
Saved in:
| Title: | The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma. |
|---|---|
| Authors: | Jones K; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.; Clinical Immunohaematology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Wockner L; Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Brennan RM; Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Keane C; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.; Clinical Immunohaematology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia., Chattopadhyay PK; ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Roederer M; ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Price DA; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK., Cole DK; Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK., Hassan B; Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK., Beck K; Tissue Engineering and Reparative Dentistry, Cardiff University School of Dentistry, Cardiff, UK., Gottlieb D; Blood and Marrow Transplant Service, Westmead Hospital, Sydney, Australia., Ritchie DS; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; University of Melbourne, Melbourne, Australia., Seymour JF; University of Melbourne, Melbourne, Australia., Vari F; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia., Crooks P; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia., Burrows SR; Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Gandhi MK; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.; Clinical Immunohaematology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia. |
| Source: | Clinical and experimental immunology [Clin Exp Immunol] 2016 Feb; Vol. 183 (2), pp. 206-20. Date of Electronic Publication: 2015 Nov 13. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26422112 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jones+K%22">Jones K</searchLink>; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.; Clinical Immunohaematology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Wockner+L%22">Wockner L</searchLink>; Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Brennan+RM%22">Brennan RM</searchLink>; Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Keane+C%22">Keane C</searchLink>; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.; Clinical Immunohaematology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Chattopadhyay+PK%22">Chattopadhyay PK</searchLink>; ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Roederer+M%22">Roederer M</searchLink>; ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Price+DA%22">Price DA</searchLink>; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Cole+DK%22">Cole DK</searchLink>; Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Hassan+B%22">Hassan B</searchLink>; Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Beck+K%22">Beck K</searchLink>; Tissue Engineering and Reparative Dentistry, Cardiff University School of Dentistry, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Gottlieb+D%22">Gottlieb D</searchLink>; Blood and Marrow Transplant Service, Westmead Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Ritchie+DS%22">Ritchie DS</searchLink>; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia.; University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Seymour+JF%22">Seymour JF</searchLink>; University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Vari+F%22">Vari F</searchLink>; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Crooks+P%22">Crooks P</searchLink>; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Burrows+SR%22">Burrows SR</searchLink>; Cellular Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Gandhi+MK%22">Gandhi MK</searchLink>; Blood Cancer Research, University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.; Clinical Immunohaematology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220057202%22">Clinical and experimental immunology</searchLink> [Clin Exp Immunol] 2016 Feb; Vol. 183 (2), pp. 206-20. <i>Date of Electronic Publication: </i>2015 Nov 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0057202 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099104%22">00099104 </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26422112 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cei.12716 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 206 Titles: – TitleFull: The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jones K – PersonEntity: Name: NameFull: Wockner L – PersonEntity: Name: NameFull: Brennan RM – PersonEntity: Name: NameFull: Keane C – PersonEntity: Name: NameFull: Chattopadhyay PK – PersonEntity: Name: NameFull: Roederer M – PersonEntity: Name: NameFull: Price DA – PersonEntity: Name: NameFull: Cole DK – PersonEntity: Name: NameFull: Hassan B – PersonEntity: Name: NameFull: Beck K – PersonEntity: Name: NameFull: Gottlieb D – PersonEntity: Name: NameFull: Ritchie DS – PersonEntity: Name: NameFull: Seymour JF – PersonEntity: Name: NameFull: Vari F – PersonEntity: Name: NameFull: Crooks P – PersonEntity: Name: NameFull: Burrows SR – PersonEntity: Name: NameFull: Gandhi MK IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2016 Feb Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1365-2249 Numbering: – Type: volume Value: 183 – Type: issue Value: 2 Titles: – TitleFull: Clinical and experimental immunology Type: main |
| ResultId | 1 |